SIMMER employs similarity algorithms to accurately identify human gut microbiome species and enzymes capable of known chemical transformations

Author:

Bustion Annamarie E12ORCID,Nayak Renuka R3,Agrawal Ayushi2ORCID,Turnbaugh Peter J45ORCID,Pollard Katherine S25678ORCID

Affiliation:

1. Pharmaceutical Sciences and Pharmacogenomics Graduate Program, University of California, San Francisco

2. Institute of Data Science and Biotechnology, Gladstone Institutes

3. Rheumatology Division, Department of Medicine, University of California, San Francisco

4. Department of Microbiology & Immunology, University of California, San Francisco

5. Chan Zuckerberg Biohub-San Francisco

6. Department of Epidemiology & Biostatistics, University of California, San Francisco

7. Institute for Human Genetics, University of California, San Francisco

8. Bakar Computational Health Sciences Institute, University of California, San Francisco

Abstract

Bacteria within the gut microbiota possess the ability to metabolize a wide array of human drugs, foods, and toxins, but the responsible enzymes for these chemical events remain largely uncharacterized due to the time-consuming nature of current experimental approaches. Attempts have been made in the past to computationally predict which bacterial species and enzymes are responsible for chemical transformations in the gut environment, but with low accuracy due to minimal chemical representation and sequence similarity search schemes. Here, we present an in silico approach that employs chemical and protein Similarity algorithms that Identify MicrobioMe Enzymatic Reactions (SIMMER). We show that SIMMER accurately predicts the responsible species and enzymes for a queried reaction, unlike previous methods. We demonstrate SIMMER use cases in the context of drug metabolism by predicting previously uncharacterized enzymes for 88 drug transformations known to occur in the human gut. We validate these predictions on external datasets and provide an in vitro validation of SIMMER’s predictions for metabolism of methotrexate, an anti-arthritic drug. After demonstrating its utility and accuracy, we made SIMMER available as both a command-line and web tool, with flexible input and output options for determining chemical transformations within the human gut. We present SIMMER as a computational addition to the microbiome researcher’s toolbox, enabling them to make informed hypotheses before embarking on the lengthy laboratory experiments required to characterize novel bacterial enzymes that can alter human ingested compounds.

Funder

PhRMA Foundation

ARCS Foundation

UCSF Benioff Center for Microbiome Medicine

Gladstone Institutes

Chan Zuckerberg Biohub San Francisco

National Institute of General Medical Sciences

National Heart, Lung, and Blood Institute

National Institute of Arthritis and Musculoskeletal and Skin Diseases

Arthritis National Research Foundation

Russell Engelman Rheumatology Research Center

University of California, San Francisco

Publisher

eLife Sciences Publications, Ltd

Subject

General Immunology and Microbiology,General Biochemistry, Genetics and Molecular Biology,General Medicine,General Neuroscience

Cited by 5 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3